Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A comprehensive evaluation of toxicity after radical hysterectomy or trachelectomy and postoperative pelvic intensity-modulated radiation therapy for cervical cancer
    Meeting Abstract

    Miller, M.; Manning-Geist, B.; Dagher, C.; Kim, S.; Kollmeier, M.; Sonoda, Y.; Jewell, E.; Park, K.; Friedman, C.; Leitao, M.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Trends and disparities in the provision of salpingectomy for surgical sterilization: The underbelly of coding, billing, and reimbursement
    Meeting Abstract

    Hazimeh, D.; Krishnamoorthi, M.; Yanek, L.; Beavis, A.; Fader, A.; Davis, J.; Roche, K. L.; Wethington, S.; Stone, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer
    Meeting Abstract

    Sullivan, M.; Graves, S.; Adkoli, A.; Zhou, Q.; Iasonos, A.; Ellenson, L.; Chi, D.; O'Cearbhaill, R.; Weigelt, B.; Grisham, R.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Gestational trophoblastic disease/neoplasm: A tertiary referral institution experience with treatment and outcomes
    Meeting Abstract

    Praiss, A.; Liu, Y.; Chiang, S.; Huang, J.; Rizzuto, G.; Weigelt, B.; Jewell, E.; Abu-Rustum, N.; Aghajanian, C.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Voices of women with low-grade serous ovarian cancer: Results from a multinational survey
    Meeting Abstract

    Sun, C.; Andrews, N.; Ludemann, J.; Larsen, E.; MacKay, C.; de Fazio, A.; Gaillard, S.; Gourley, C.; Carey, M.; Fader, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Use of ChatGPT for management recommendations in advanced ovarian cancer
    Meeting Abstract

    Finch, L.; Broach, V.; Feinberg, J.; Roche, K. L.; Gardner, G.; Sonoda, Y.; Abu-Rustum, N.; Chi, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • nab-Sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer: A phase II, open-label, single-arm, prospective, multicenter study
    Meeting Abstract

    Dockery, L.; Slomovitz, B.; Priebe, A.; Green, A.; Mathews, C.; Musa, F.; Puechl, A.; Birrer, M.; Spirtos, N.; Ding, L.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of ubamatamab (REGN4018), a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab (anti-PD-1) in patients with recurrent ovarian cancer or MUC16+endometrial cancer: Trial in progress update
    Meeting Abstract

    Liu, J.; O'Malley, D.; Van Nieuwenhuysen, E.; O'Cearbhaill, R.; Bouberhan, S.; Moore, K.; Hou, J.; Hamilton, E.; Yoo, S. Y.; Wang, B.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer
    Meeting Abstract

    Girda, E.; Makker, V.; Marth, C.; Van Gorp, T.; Mirza, M.; Shapira-Frommer, R.; Suttner, L.; Groisberg, R.; Jin, F.; O'Malley, D.
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
    Meeting Abstract

    Pothuri, B.; Valabrega, G.; Oaknin, A.; Graybill, W.; Sánchez, A. B.; McCormick, C.; Baurain, J. F.; Tinker, A.; Denys, H.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save